Answers are grounded in this paper and cite their sources.
These findings suggest that tumor infiltrating immune cells can be differentiated by immune-specific gene expression patterns that quantify the relative abundance of multiple immune infiltrates across a range of solid tumor types. That these markers of immune involvement are significantly associated with patient prognosis in diverse cancers suggests their clinical utility as pan-cancer markers of tumor behavior and immune responsiveness.
No takes yet. Share an insight, caveat, or question.
Chifman et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: